| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |